Navigation Links
Penn researchers identify potential target for breast cancer therapy
Date:12/22/2010

und that P-Rex1 is present in some breast tumors, particularly those that express the Her2/neu receptor or estrogen receptor and belong to the luminal subtype.

"We found that about two-thirds of the patient samples had very high levels of P-Rex1 expression in tumor cells in their lymph nodes," Kazanietz says. "There seems to be a correlation between P-Rex1 expression in the tumor cells and the capacity of these cells to metastasize. And since P-Rex1 is likely to be essential for cell migration and migration is essential for metastasis, we believe blocking this pathway could reduce the risk of metastasis."

P-Rex1 may be important for several other cancer-promoting pathways. For example, estrogen-receptor signaling also appears to rely on P-Rex1, which means that targeted inhibitors of P-Rex1 might improve responses to anti-estrogen therapies such as tamoxifen.

The authors also found that P-Rex1 is also used by another receptor, CXCR4, which has recently shown up in many cancer studies. Despite being used in numerous pathways during cancerous growth, P-Rex1 is not expressed in many normal tissues. "That gives us a very good target. It is really cancer specific," Kazanietz says. "What's more, as P-Rex1 is expressed in some subtypes of breast tumors, it may be an excellent prototype for future personalized medicine."

Preclinical data from other groups supports the importance of the Rac pathway in cancer, according to Kazanietz. And small molecule inhibitors that block proteins in the Rac pathway appear to have strong anti-cancer effects in model systems, though their use in patients still needs to be tested.


'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Researchers Turn White Fat to Energy-Burning Brown Fat in Mice
2. Finnish researchers find a compound that prevents the growth of prostate cancer cells
3. Ben-Gurion U. researchers: High resistance rates among acute otitis media pathogens in children
4. Breast inflammation is key to cancer growth, Kimmel Cancer Center researchers say
5. Researchers discover new signaling pathway linked to inflammatory disease
6. UCI researchers find novel memory-enhancing mechanism in brain
7. Researchers make critical leukemia stem cell discovery
8. U-M researchers discover way to block neurodegeneration in an adult form of Fragile X syndrome
9. Leibniz Prize 2011: 10 researchers awarded €2.5 million ($3.3 million) each
10. Researchers Turn Stem Cells Into Intestinal Tissue in Lab
11. Expert analysis of HER2 tests reveals issues with reliability, Mayo Clinic researchers say
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Penn researchers identify potential target for breast cancer therapy
(Date:8/31/2015)... ... ... Dr. Stewart Shofner of Shofner Vision Center explains what causes lazy ... eye examination can diagnose amblyopia. According to the National Eye Institute (NEI), ... to 3 out of every 100 children. , Dr. Shofner adds, “unless amblyopia ...
(Date:8/31/2015)... ... August 31, 2015 , ... Nine innovative healthcare companies (listed ... in Healthcare(SM) Awards Event , on October 21, 2015, in Long Beach. The ... organizations and individuals who are dramatically reducing the cost of quality healthcare. , ...
(Date:8/31/2015)... ... 2015 , ... Finnleo is pleased to announce another in a ... of extensive engineering and design of our newest sauna model, the Terrace combines high ... offered at a very attractive price-point. , Before outdoor saunas were a dream ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... and accessible primary care, is enhancing its existing presence in Tennessee with the ... The location is the company’s second in Knoxville, sixteenth in Tennessee, and 148th ...
(Date:8/31/2015)... New York (PRWEB) , ... August 31, 2015 , ... ... autumn, when play-offs and the World Series will dominate the sports world. Fans desire ... and eventually advance to the final series. For children, especially those who are too ...
Breaking Medicine News(10 mins):Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 2Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 4Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 5Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 6Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 7Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 8Health News:Say “Hello” to the Brand New Finnleo Terrace Outdoor Saunas 2Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:New Children's Baseball Series Offers Young Fans a Way to Celebrate the World Series 2
... illusion; ridiculous, says former star major league pitcher , FRIDAY, ... the pitcher,s hand. In less than a second, it curves ... , The curveball, when thrown correctly, is one of baseball,s ... and not so great have sworn that the ball seems ...
... FRANCISCO, Calif., Oct. 30 Anesiva, Inc. (Nasdaq: ANSV ... Stockholders will be held on December 3, 2009 at 9:00 ... Francisco, California. Stockholders of record at the close of ... at the 2009 Annual Meeting of Stockholders. The definitive ...
... (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, ... Tablets, at a major psychiatric medical meeting today. ... the change from baseline on the oppositional subscale of ... in patients ages 6 to 12 with a primary ...
... around right after procedure cuts conception rate, study found ... lie flat for 15 minutes after being artificially inseminated ... suggests. , "Allowing women treated for subfertility with IUI ... a 50 percent higher chance at conceiving," said Inge ...
... ... joined the crusade to better our environment by offering green printing services and eco-friendly ... information for the company,s custom labels offering. , ... Fort Scott, KS (PRWEB) October 30, 2009 --, , ...
... infants, studies show , FRIDAY, Oct. 30 (HealthDay ... who should get H1N1 swine flu and seasonal flu ... vaccination for moms-to-be and their babies. , Bigger, healthier ... top the findings, which are to be presented this ...
Cached Medicine News:Health News:Scientist Throws Curve Into Breaking-Ball Debate 2Health News:Scientist Throws Curve Into Breaking-Ball Debate 3Health News:Anesiva Announces Date for 2009 Annual Meeting of Stockholders to Vote on Proposed Merger 2Health News:Anesiva Announces Date for 2009 Annual Meeting of Stockholders to Vote on Proposed Merger 3Health News:INTUNIV demonstrated symptom reduction on oppositional subscale Conners' ADHD rating scale 2Health News:INTUNIV demonstrated symptom reduction on oppositional subscale Conners' ADHD rating scale 3Health News:Lying Still Raises Artificial Insemination Success 2Health News:Lying Still Raises Artificial Insemination Success 3Health News:My1Stop.com Launches New Custom Labels Solutions Making Pricing and Ordering Faster and Easier 2Health News:Flu Shot in Pregnancy Protects Baby 2Health News:Flu Shot in Pregnancy Protects Baby 3
(Date:8/31/2015)...   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue ... media and a related cloud hosted biologistics ... shippers ("BioLife" or the "Company"), today announced ... company focused on developing and commercializing novel therapeutics ...
(Date:8/29/2015)... 2015 La sofisticada aplicación ... sistemas de imagen por Ultrasonidos   ofrece resultados más ... rápidos y un flujo de trabajo   optimizado, lo ... proceso de detección de Cardiopatías   ... el lanzamiento europeo de HeartModel A.I ...
(Date:8/28/2015)... , August 28, 2015 ... Market by Tumor (Breast, Lung, Prostate) Type (Protein & ... (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast ... is expected to reach around 17,689.0 Million USD by ... period of 2015 to 2020. Browse ...
Breaking Medicine Technology:BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5
... MacroChem Corporation (OTC,Bulletin Board: MACM) today announced results ... who completed a 48-week, U.S. multi-center,open-label efficacy and ... the treatment of onychomycosis (nail fungus). The composite,primary ... defined as,negative mycology (negative fungal culture and negative ...
... Sound Pharmaceuticals (SPI) has filed,an Investigational New ... of a proprietary formulation of ebselen for the ... oral capsule,containing ebselen, SPI-3005, will be tested in ... patients receiving platinum based chemotherapy.,This marks the second ...
Cached Medicine Technology:MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
The HT-PB is a implantable bipolar tined permanent pacing lead for stimulation of the ventricle....
... Flextend lead is a ... with an extendable/retractable active-fixation ... design offers various lead ... implantation in the atrium ...
The RU is a low profile implantable bipolar tined permanent pacing lead for stimulation of either the atrium (J model) or the ventricle (straight model)....
Medicine Products: